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T
he connections that cells make 
with their neighbors and with 
their extracellular matrix are es-
sential for keeping our bodies in one 
piece. But the loss or modifi  cation  of 
these connections is also essential for nu-
merous processes, such as cell migration 
and cell division.
How cells control the dynamics of 
building and destroying their bonds was a 
question that piqued Kris DeMali’s inter-
est during her PhD studies on cell signal-
ing pathways that prompt mitosis (1–3). 
So much so, in fact, 
that she switched her 
focus to cell adhesion 
for her post-doctoral 
studies (4–6).
Now, as a group 
leader at the Univer-
sity of Iowa, DeMali 
is continuing her 
studies into cell ad-
hesion, and is partic-
ularly interested in 
the changes in cell 
stickiness that are as-
sociated with can-
cer—such as when 
tumor cells start to 
metastasize. DeMali, 
who moved to the 
university two and a half years ago with a 
Howard Temin Award from the National 
Cancer Institute, was kind enough to loos-
en herself from the laboratory bench mo-
mentarily and talk with us at JCB.
COUNTRY ROOTS
Where did you grow up?
On a small farm in rural Ohio. It was a 
small dairy operation. We had mostly cat-
tle, plus a few pigs and chickens and a lot 
of maize.
Did farm life prompt your interest 
in science and nature?
It probably awakened my interest in sci-
ence, but I didn’t recognize it at that 
point. Growing up on a small farm, I 
wasn’t exposed to people who did scien-
tifi   c research. But I liked my science 
classes in high school, so I thought I’d go 
to medical school.
You weren’t tempted to become a vet?
No! [laughs]. I think people who grow up 
on farms don’t want to be vets.
So how did an interest in medicine turn 
into an interest in science?
I took a chemistry course during my fi  rst 
semester at the College of Wooster in 
Ohio, and I met a chemistry professor 
named Ted Williams who gave me a 
summer job in his laboratory. I had to 
identify and dispose of all the unlabeled 
chemical waste that had accumulated 
over the years from the experiments that 
had been performed in the organic teach-
ing laboratory.
That sounds like a lovely job. I can see 
why you were hooked.
[Laughs]. It was a terrible job, but it ac-
tually ended up being quite fun. I started 
off the summer with a bench full of 
four-liter bottles fi   lled with unknown 
organic waste, and it was a real chal-
lenge to identify what they were. I pro-
gressed pretty rapidly, and because there 
was still time left in the summer, he let 
me begin a research project. It was re-
ally that summer job that made me stick 
with science.
UPROOTED
Where did you do your PhD?
I started my PhD at the University of 
Colorado Health Sciences Center in Den-
ver with Andrius Kazlauskas, studying 
the downstream signals from the PDGF 
receptor. About midway through my 
graduate career, he moved to take a fac-
ulty appointment at Schepens Eye Re-
search Institute, affi   liated with Harvard 
Medical School, in Boston. So I moved 
with him.
Were you happy to move?
No, I wasn’t happy at all! I was actually 
quite angry. I had chosen Denver because 
it was a reasonably sized city to live in. 
Being from rural Ohio, the thought of liv-
ing in Boston and not owning a car was 
quite a scary prospect.
But I made the move, and I quickly 
learned to love Boston. It was a very ex-
citing place to do science. There were so 
many seminars going on every day that 
were directly related to the kind of re-
search that we did, and there was such a 
big volume of people doing science, that 
it was a really fun place to be.
What was your project?
I studied PDGF receptor signaling, and 
tried to determine how, in certain con-
texts, it drives cellular transformation. 
Over the course of my studies I became 
interested in the fact that transformation 
has to be accompanied by changes in the 
adhesive properties of cells. I became so 
interested that I decided to pursue post-
doctoral studies with Keith Burridge, 
who’s a leading cell adhesion researcher 
at Chapel Hill North Carolina.
How did the project develop in Keith’s 
laboratory?
Because I was changing fi  elds—from 
growth factor receptor signaling to work-
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ing on adhesion—when I fi  rst joined the 
laboratory, I relied pretty heavily on 
Keith for project ideas. We began inves-
tigating whether or not there was a link 
between the actin polymerization ma-
chinery, Arp2/3, and integrins, which at-
tach cells to the extracellular matrix.
We soon found out there was a link, 
and it was the integrin-associated pro-
tein, vinculin. I then discovered the two 
are not connected all the time. They 
only interact when the cell is stimulated 
by epidermal growth factor, or the ex-
tracellular matrix protein fi  bronectin—
such as when the cell has to change its 
adhesive properties to go through mito-
sis or to migrate.
NEW ROOTS AND ROUTES
And you’re still working on vinculin?
Yes. Most of my post-doc work was fo-
cused on cell-to-matrix adhesions, but 
some people in Keith’s laboratory began 
to study transendothelial migration—
when cells such as leukocytes have to 
squeeze through the endothelial lining of 
the blood vessels to access the tissues. 
During this migration the endothelial cells 
have to alter their cell-to-cell adhesions to 
let the leukocytes through. That started 
me thinking about vinculin’s role in cell-
to-cell adhesions.
Is there evidence of a role for vinculin 
in cell–cell contact?
There is substantial literature that sug-
gests vinculin plays a role at adherens 
junctions. However, most studies are 
performed using gene deletion ap-
proaches, which eliminates vinculin at 
both cell–matrix and cell–cell adhesion 
sites. So my laboratory has been devot-
ing a signifi  cant amount of time to gen-
erating a powerful vinculin knockdown 
substitution system. First, we knock-
down the endogenous vinculin by RNAi 
and then we add back a fl  uorescently la-
beled vinculin.
How does the method differentiate 
between the cell–cell junctions and the 
cell–matrix attachments?
The turnover of vinculin in cell–cell ad-
hesions is much more rapid than the turn-
over in cell–matrix adhesions. When we 
inhibit ∼70–80% of the vinculin, it leaves 
intact the vinculin at sites of cell–matrix 
adhesion, and only removes vinculin’s 
function in cell–cell adhesion. Our results 
show that when we add the fl  uorescent 
version of the protein, we are looking at 
vinculin at the cell–cell junctions.
So what have you discovered?
We’re very close to ascribing a function 
for vinculin at the cell–cell junctions. 
But we’ve not published it yet. In short, 
what we’ve found is that vinculin is one 
of the proteins that appears to be in-
volved in dynamic changes in adhesive 
properties that occur during processes 
such as transendothelial migration, mi-
tosis, embryonic development, or wound 
healing.
What’s up next for you?
First we want to establish vinculin’s func-
tion, and then we’ll pursue how it fi  ts into 
the broader context of mitosis, migration, 
disease, etc. I think those are all exciting 
avenues to pursue in the future.
We’re also interested in what hap-
pens to vinculin in cancer, as loss of 
vinculin is associated with disease pro-
gression and poor prognosis. I think one 
of the things I learned during my gradu-
ate and post-doctoral studies is that you 
just go where the science takes you. So 
I look forward to being taken down all 
sorts of paths.
What do you like best about being a PI?
I really love mentoring my students—
I have two graduate students and two 
undergrads. I like conveying to them 
my excitement about 
science, but also see-
ing their own excite-
ment too.
The major chal-
lenge for all young 
PIs, of course, is 
funding, and I’m no 
different. But the de-
partment I’m in has a 
strong commitment 
to mentoring young 
scientists, and I think 
that’s the key to suc-
cess in science, espe-
cially in the current 
funding climate. Also, I really like be-
ing in Iowa. It’s a small college town, 
and I like that setting. It takes me back 
to my roots.
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Vinculin (green) colocalizes with a cell–cell 
adhesion protein (red).
At a migrating cell’s leading edge vinculin 
and an actin regulator come together 
(arrows), enabling the cell to send out 
protrusions, grab hold of the matrix, and 
move forward.
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